Literature DB >> 16183412

Obesity and prevalent and incident CKD: the Hypertension Detection and Follow-Up Program.

Holly Kramer1, Amy Luke, Anil Bidani, Guichan Cao, Richard Cooper, Dan McGee.   

Abstract

BACKGROUND: Obesity is associated with increased single-nephron glomerular filtration rate, which may increase the risk for chronic kidney disease (CKD), especially when combined with hypertension. However, epidemiological data supporting an association between overweight and obesity and risk for CKD currently are limited.
METHODS: We used data from the Hypertension Detection and Follow-Up Program (HDFP) to test the hypothesis that overweight and obesity are associated with incident CKD in 5,897 hypertensive adults. Serum and spot urine samples were collected at baseline and year 5. CKD is defined as the presence of 1+ or greater proteinuria on routine urinalysis and/or an estimated glomerular filtration rate less than 60 mL/min/1.73 m2 (<1.0 mL/s).
RESULTS: In HDFP participants without CKD at baseline, the incidence of CKD at year 5 was 28% in the ideal-body-mass-index group, 31% in the overweight group, and 34% in the obese group. After adjustment for all covariates, including diabetes mellitus, mean baseline diastolic blood pressure, and slope of diastolic blood pressure, both baseline overweight (odds ratio [OR], 1.21; 95% confidence interval [CI], 1.05 to 1.41) and obesity (OR, 1.40; 95% CI, 1.20 to 1.63) were associated with increased odds of incident CKD at year 5. Similar results were noted after exclusion of participants with baseline diabetes mellitus, with both overweight (OR, 1.22; 95% CI, 1.05 to 1.43) and obesity (OR, 1.38; 95% CI, 1.17 to 1.63) remaining significantly associated with incident CKD.
CONCLUSION: These results suggest that obese adults with hypertension have an increased risk for CKD.

Entities:  

Mesh:

Year:  2005        PMID: 16183412     DOI: 10.1053/j.ajkd.2005.06.007

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  112 in total

Review 1.  Sleep disturbances as nontraditional risk factors for development and progression of CKD: review of the evidence.

Authors:  Nicolas F Turek; Ana C Ricardo; James P Lash
Journal:  Am J Kidney Dis       Date:  2012-06-21       Impact factor: 8.860

Review 2.  The link between the renin-angiotensin-aldosterone system and renal injury in obesity and the metabolic syndrome.

Authors:  Tina Thethi; Masumi Kamiyama; Hiroyuki Kobori
Journal:  Curr Hypertens Rep       Date:  2012-04       Impact factor: 5.369

Review 3.  Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic Strategies.

Authors:  Prasenjit Manna; Sushil K Jain
Journal:  Metab Syndr Relat Disord       Date:  2015-12       Impact factor: 1.894

4.  Oxidative stress and inflammation are associated with adiposity in moderate to severe CKD.

Authors:  Luis F Ramos; Ayumi Shintani; T Alp Ikizler; Jonathan Himmelfarb
Journal:  J Am Soc Nephrol       Date:  2008-02-06       Impact factor: 10.121

5.  Association of body mass index with outcomes in patients with CKD.

Authors:  Jun Ling Lu; Kamyar Kalantar-Zadeh; Jennie Z Ma; L Darryl Quarles; Csaba P Kovesdy
Journal:  J Am Soc Nephrol       Date:  2014-03-20       Impact factor: 10.121

6.  Urinary biomarkers track the progression of nephropathy in hypertensive and obese rats.

Authors:  Qin Zhang; Kelly J Davis; Dana Hoffmann; Vishal S Vaidya; Ronald P Brown; Peter L Goering
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

7.  The effect of biliopancreatic diversion surgery on renal function--a retrospective study.

Authors:  Biju Jose; Stephen Ford; Paul Super; G Neil Thomas; Indranil Dasgupta; Shahrad Taheri
Journal:  Obes Surg       Date:  2013-05       Impact factor: 4.129

8.  Simvastatin and tempol protect against endothelial dysfunction and renal injury in a model of obesity and hypertension.

Authors:  Sarah F Knight; Jianghe Yuan; Siddhartha Roy; John D Imig
Journal:  Am J Physiol Renal Physiol       Date:  2009-11-11

9.  Impact of obesity on renal structure and function in the presence and absence of hypertension: evidence from melanocortin-4 receptor-deficient mice.

Authors:  Jussara M do Carmo; Lakshmi S Tallam; John V Roberts; Elizabeth L Brandon; John Biglane; Alexandre A da Silva; John E Hall
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-07-15       Impact factor: 3.619

10.  Obesity and change in estimated GFR among older adults.

Authors:  Ian H de Boer; Ronit Katz; Linda F Fried; Joachim H Ix; Jose Luchsinger; Mark J Sarnak; Michael G Shlipak; David S Siscovick; Bryan Kestenbaum
Journal:  Am J Kidney Dis       Date:  2009-09-25       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.